Le Lézard
Classified in: Health, Science and technology
Subject: Personnel

Aryballe Appoints Pierre Chauvineau as New Chairman of the Board


Aryballe, the pioneer in digital olfaction, announced today it has appointed Pierre Chauvineau as its new Chairman of the Board. Aryballe's board provides the company with business and technological guidance based on combined decades of digital technology, healthcare, science, and consumer executive experience.

With three decades of leadership in enterprise and startup environments, Chauvineau joins Aryballe to provide assistance and guidance as the company transitions into a period of mass production and widespread adoption of its digital olfaction sensors. He brings a diverse range of international corporate and startup experience in evolving deep tech startups into product and commercialization phases.

"Aryballe is fortunate to have Pierre's deep expertise as we move into this next phase of technological expansion and deploy our products at scale," said Sam Guilaumé, Aryballe CEO. "His experience advising the strategic growth of companies on a similar trajectory as Aryballe, across an international landscape, will be an asset as we continue to expand our customer base and industry applications."

Chauvineau began his career with Medtronic where he spent 20 years working in roles including country manager and head of multiple regional business units. In 2010, he joined Cameron Health, a venture-backed company based in California, and stayed with the company through its acquisition by Boston Scientific (BSC). He went on to serve as the head of BSC's largest business unit in EMEA for five years. He has also served in various startup advisory roles including on boards, and as an academic advisor to universities across Europe on business and innovation topics.

"Aryballe is a strong, innovative company that is well-positioned for significant growth in the digital olfaction market," said Chauvineau. "Aryballe's technology has incredible potential for commercialization across varied industries and I'm excited to work with Aryballe's executive team to continue innovating in this space."

Chauvineau will assume the position of Chairman of the Board from Jean-Christophe Simon, who has held the position since 2018 and has successfully guided the company through several critical milestone events including the launches of the DOAC and the NeOse Advance for Aryballe's customers in food, flavor and fragrances. Simon will continue to support Aryballe in an advisory capacity on IP and technology issues.

"Jean-Christophe has been instrumental in advancing Aryballe's vision" said Guilaumé. "We are grateful for his leadership and welcome his ongoing expertise as he continues to serve Aryballe in an advisory role."

About Aryballe

Based in Grenoble, France and founded in 2014, Aryballe combines biochemistry, advanced optics and machine learning to mimic the human sense of smell. The company's premier product offering, NeOse Advance, uses silicon photonics technology to detect, record and recognize odor data, which powers improved decision making for R&D, quality control, manufacturing and end-user experiences. Aryballe Suite, the company's cloud-enabled software, enables customers to intuitively access and customize analysis of odors based on their unique needs. With operations in France, South Korea and the USA, Aryballe works with global leaders in automotive, consumer appliances, food manufacturing and flavor & fragrances.


These press releases may also interest you

at 19:01
Today, the Minister of Public Safety and Emergency Preparedness, the Honourable Bill Blair, confirmed that the Government has approved a Request for Federal Assistance to provide surge capacity support to the Northwest Territories with infection...

at 19:00
With the worldwide healthcare industry commemorating International Infection Prevention Week, October 17-23, MINTIE LLC, a third-generation healthcare product innovator and an Alliance Environmental Group company, continues its efforts at infection...

at 19:00
The medical device manufacturing outsourcing market is expected to grow by USD 27.12 billion and record a CAGR of 7.81% from 2021 to 2025, according to the latest market research report by Technavio. The growth can be mainly attributed to the growing...

at 18:15
Small Pharma Inc. (the "Company" or "Small Pharma"), a neuropharmaceutical company focused on psychedelic-assisted therapies, today announced that the previously issued: (i) audited consolidated financial statements for the fiscal year ended...

at 18:00
The "Protein Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global protein therapeutics market exhibited moderate growth during...

at 17:54
ViewRay, Inc. announced today that the company will host a Virtual Clinical Data Event for Investors and Analysts on Thursday, October 28, 2021. The event will begin at 8:30 am ET / 5:30 am PT. The Virtual Clinical Data Event will be hosted by...



News published on 23 september 2021 at 03:05 and distributed by: